Found: 3
Select item for more details and to access through your institution.
A RETROSPECTIVE STUDY OF 222 PATIENTS WITH NEWLY DIAGNOSED PRIMARY CNS LYMPHOMA—OUTCOMES INDICATIVE FOR IMPROVED SURVIVAL OVERTIME.
- Published in:
- Hematological Oncology, 2023, v. 41, p. 692, doi. 10.1002/hon.3165_545
- By:
- Publication type:
- Article
REAL‐LIFE EXPERIENCE WITH RITUXIMAB‐DOSE‐ADJUSTED EPOCH (R‐da‐EPOCH) IN PRIMARY MEDIASTINAL LARGE B‐CELL LYMPHOMA (PMLBCL): A MULTINATIONAL ANALYSIS OF 274 PATIENTS.
- Published in:
- Hematological Oncology, 2023, v. 41, p. 410, doi. 10.1002/hon.3164_301
- By:
- Publication type:
- Article
RITUXIMAB‐DOSE‐ADJUSTED EPOCH (R‐DA‐EPOCH) IN PRIMARY MEDIASTINAL LARGE B‐CELL LYMPHOMA (PMLBCL): REAL‐LIFE EXPERIENCE ON 190 PATIENTS FROM 3 MEDITERRANEAN COUNTRIES.
- Published in:
- Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.76_2880
- By:
- Publication type:
- Article